Clinical Trials in Houston

Showing 2121-2140 of 8,625 trials

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

NCT05387265

The purpose of this first-in-human study, CTMX-904-101, is to characterize the safety, tolerability, pharmacokinetics (PK), pharmacodynamics (PD) and antitumor activity of CX-904 in adult subjects with metastatic or locally advanced unresectable solid tumors.

Solid Tumors

CytomX Therapeutics83 participantsStarted May 2022

Denver, Colorado, United States • Nashville, Tennessee, United States • Houston, Texas, United States +2 more locations

SUSPENDEDNA< 1 mile

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish Language

NCT06487806

The purpose of this study is to test the usability, engagement and acceptability of SmokefreeSGM Español, a culturally and linguistically tailored version of SmokefreeSGM, among Spanish-speaking SGM smokers.

Smoking Cessation

The University of Texas Health Science Center, Houston20 participantsStarted Aug 2024

Houston, Texas, United States

COMPLETEDPhase 2< 1 mile

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

NCT05328297

The purpose of this study is to evaluate the efficacy of JNJ-55308942 compared to placebo on symptoms of depression in participants with bipolar disorder (BD) in a major depressive episode (MDE) at Week 6.

Bipolar Disorder

Janssen Pharmaceutica N.V., Belgium116 participantsStarted Jun 2022

Huntsville, Alabama, United States • Little Rock, Arkansas, United States • Lemon Grove, California, United States +41 more locations

A Trial to Find Safe and Active Doses for an Investigational Drug, CX-904, for Patients With Advanced Solid Tumors

SmokefreeSGM Español Pilot, Beta Testing a Text-based Smoking Cessation Intervention for Sexual and Gender Minority(SGM) Groups Preferring Spanish Language

A Study of JNJ-55308942 in the Treatment of Bipolar Depression

Find Trials by Condition in Houston

A Phase 3 Study Evaluating the Efficacy and Safety of OCS-01 Eyedrops Compared to Vehicle for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery

Study of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)

Study of mRNA-1010 Seasonal Influenza Vaccine in Adults

Fetoscopic Meningomyelocele Repair Study

A Study to Investigate the Safety and Efficacy of TMP-301 Compared to Placebo in Adult Patients With Alcohol Use Disorder

Phase 4 Study: Long-term Safety and Efficacy of NT-501 in MacTel Type 2, Including Sham Procedure Participants

A Study in Participants With Non-cirrhotic NASH With Fibrosis

Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking Surgery

Nurturing Healthy Teachers

Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients

The GUARD Trial - Part 1: A Phase 3 Clinical Trial for Prevention of Proliferative Vitreoretinopathy

A Study to Determine the Safety and Efficacy of NT-501 With MHFM

A Research Study to See How Well the New Weekly Medicine IcoSema, Which is a Combination of Insulin Icodec and Semaglutide, Controls Blood Sugar Level in People With Type 2 Diabetes Compared to Weekly Semaglutide (COMBINE 2)

89Zr-girentuximab for PET Imaging of CAIX Positive Solid Tumors

LSALT Peptide vs. Placebo to Prevent ARDS and Acute Kidney Injury in Patients Infected With SARS-CoV-2 (COVID-19)

The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global)

Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)